Harvard Law School Professor I. Glenn Cohen, faculty director of the School’s Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics spoke with the Harvard Gazette about Monday’s ruling by the Supreme Court that overturned a Texas law requiring that abortion clinics maintain hospital-like standards at their facilities as well as admitting privileges at local hospitals.
When a severe speech impediment left him struggling to be understood, food became a way for Tommy Tobin ’16 to connect with others. In high school he volunteered at a food bank and with the Boys & Girls Clubs of America, and watched his actions speak volumes. “Speaking through service became a theme for me.”
“FDA in the 21st Century: The Challenges of Regulating Drugs and New Technologies,” edited by Holly Fernandez Lynch and I. Glenn Cohen ’03 (Columbia). Stemming from a 2013 conference at HLS, the book features essays covering major developments that have changed how the FDA regulates; how the agency encourages transparency; First Amendment issues; access to drugs; and evolving issues in drug-safety communication. These issues, the editors write, lie “at the heart of our health and health care.”
Each year, teams of Harvard Law School students are given the opportunity to spend their Spring Break experiencing legal services work with clinics and legal organizations in the Boston area, or working on projects around the country and abroad–here, a few students share their accounts, reflecting on the significance of their service.
Across HLS, faculty are focusing on international access to lifesaving drugs for underserved populations. One forthcoming book, “The Health Crisis in the Developing World and What We Should Do About It,” by Professor William W. Fisher ’82 and Talha Syed, addresses just such issues. “We need to immunize residents (preferably while they are children) against […]